[1] |
STARZL TE, IWATSUKI S, VAN THIEL DH, et al. Evolution of liver transplantation[J]. Hepatology, 1982, 2(5): 614-636. DOI: 10.1002/hep.1840020516.
|
[2] |
YOUNG K, LIU B, BHUKET T, et al. Lower likelihood of post-transplant graft failure, death, and retransplantation in the era of direct-acting antivirals[J]. J Clin Exp Hepatol, 2020, 10(6): 581-589. DOI: 10.1016/j.jceh.2020.02.003.
|
[3] |
DAKROUB A, ANOUTI A, COTTER TG, et al. Mortality and morbidity among adult liver retransplant recipients[J]. Dig Dis Sci, 2023, 68(10): 4039-4049. DOI: 10.1007/s10620-023-08065-2.
|
[4] |
MEZOCHOW AK, ABT PL, BITTERMANN T. Differences in early immunosuppressive therapy among liver retransplantation recipients in a national cohort[J]. Transplantation, 2021, 105(8): 1800-1807. DOI: 10.1097/ TP.0000000000003417.
|
[5] |
KULIK U, LEHNER F, KLEMPNAUER J, et al. Primary non-function is frequently associated with fatty liver allografts and high mortality after re-transplantation[J]. Liver Int, 2017, 37(8): 1219-1228. DOI: 10.1111/liv.13404.
|
[6] |
张龙, 韩国勇, 陈志强, 等. 再次肝移植治疗慢性移植物功能衰竭4例报告及文献复习[J]. 南京医科大学学报(自然科学版), 2024, 44(2): 247-252. DOI: 10.7655/NYDXBNSN230913.ZHANG L, HAN GY, CHEN ZQ, et al. Report and research progress on liver re-transplantation for chronic graft failure in 4 cases[J]. J Nanjing Med Univ, 2024, 44(2): 247-252. DOI: 10.7655/NYDXBNSN230913.
|
[7] |
HALLE-SMITH JM, HALL LA, HANN A, et al. Emergency retransplant for primary non-function of liver allograft[J]. Br J Surg, 2023, 110(10): 1267-1270. DOI: 10.1093/bjs/znad110.
|
[8] |
杨梦凡,王睿,潘斌华,等. 脂肪变性供肝用于肝癌肝移植的预后及影响因素多中心研究[J].中华消化外科杂志, 2022, 21(2): 237-248. DOI: 10.3760/cma.j.cn115610-20220209-00072.YANG MF, WANG R, PAN BH, et al. Analysis of influencing factors for anastomotic biliary stricture after liver transplantation[J]. Chin J Dig Surg, 2022, 21(2): 237-248. DOI: 10.3760/cma.j.cn115610-20220209-00072.
|
[9] |
KURAMITSU K, FUKUMOTO T, EGAWA H, et al. A multicenter Japanese survey assessing the long-term outcomes of liver retransplantation using living donor grafts[J]. Transplantation, 2020, 104(4): 754-761. DOI: 10.1097/TP.0000000000002958.
|
[10] |
NEVES SOUZA L, DE MARTINO RB, SANCHEZ-FUEYO A, et al. Histopathology of 460 liver allografts removed at retransplantation: a shift in disease patterns over 27 years[J]. Clin Transplant, 2018, 32(4): e13227. DOI: 10.1111/ctr.13227.
|
[11] |
PAWLICKI J, KUREK A, KRÓL R. Evaluation of early and late effects of surgical treatment of early hepatic artery thrombosis after liver transplantation[J]. Transplant Proc, 2022, 54(4): 1037-1041. DOI: 10.1016/j.transproceed.2022.03.016.
|
[12] |
YOON PD, PATEL MS, MURILLO PEREZ CF, et al. Outcomes of adult liver retransplantation: a Canadian national database analysis[J]. Can J Gastroenterol Hepatol, 2022: 9932631. DOI: 10.1155/2022/9932631.
|
[13] |
JEFFREY AW, DELRIVIERE L, MCCAUGHAN G, et al. Excellent contemporary graft survival for adult liver retransplantation: an Australian and New Zealand registry analysis from 1986 to 2017[J]. Transplant Direct, 2019, 5(8): e472. DOI: 10.1097/TXD.00000 00000000920.
|
[14] |
CROOME KP, MATHUR AK, PUNGPAPONG S, et al. Equivalent outcomes with retransplantation and primary liver transplantation in the direct-acting antiviral era[J]. Transplantation, 2019, 103(6): 1168-1174. DOI: 10.1097/TP.0000000000002460.
|
[15] |
PHILIP G, HOOKEY L, RICHARDSON H, et al. Alcohol-associated liver disease is now the most common indication for liver transplant waitlisting among young American adults[J]. Transplantation, 2022, 106(10): 2000-2005. DOI: 10.1097/TP.0000000000004202.
|
[16] |
FALARI SS, MOHAPATRA N, PATIL NS, et al. Incidence and predictors of alcohol relapse following living donor liver transplantation for alcohol related liver disease[J]. J Hepatobiliary Pancreat Sci, 2023, 30(8): 1015-1024. DOI: 10.1002/jhbp.1325.
|
[17] |
COTTER TG, ODENWALD MA, LIEBER SR, et al. The practice of retransplantation for recurrent alcohol-associated liver disease in the United States is uncommon with acceptable outcomes[J]. Transplant Direct, 2022, 8(3): e1297. DOI: 10.1097/TXD.0000000000 001297.
|
[18] |
VISSEREN T, ERLER NS, POLAK WG, et al. Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond[J]. Transpl Int, 2021, 34(8): 1455-1467. DOI: 10.1111/tri.13925.
|
[19] |
HENSON JB, PATEL YA, KING LY, et al. Outcomes of liver retransplantation in patients with primary sclerosing cholangitis[J]. Liver Transpl, 2017, 23(6): 769-780. DOI: 10.1002/lt.24703.
|
[20] |
LÓPEZ MJC, FRANCO CC, ARTACHO GS, et al. Results of early liver retransplantation[J]. Transplant Proc, 2020, 52(5): 1486-1488. DOI: 10.1016/j.transproceed. 2020.02.055.
|
[21] |
SHIMADA S, SHAMAA T, IVANICS T, et al. Effects of the implementation of acuity circle policy on waitlist and post-transplant outcomes of liver re-transplantation[J]. Clin Transplant, 2023, 37(6): e14977. DOI: 10.1111/ctr.14977.
|
[22] |
ABBASSI F, GERO D, MULLER X, et al. Novel benchmark values for redo liver transplantation: does the outcome justify the effort?[J]. Ann Surg, 2022, 276(5): 860-867. DOI: 10.1097/SLA.0000000000005634.
|
[23] |
LLADÓ L, LOPEZ-DOMINGUEZ J, RAMOS E, et al. Is liver retransplantation justified in the current era?[J]. Cir Esp (Engl Ed), 2021, 99(5): 339-345. DOI: 10.1016/j.ciresp.2020.06.023.
|
[24] |
SMOTER P, KRASNODĘBSKI M, FIGIEL W, et al. The effect of early retransplantation on early and late survival after liver transplantation[J]. Transplant Proc, 2022, 54(4): 1007-1010. DOI: 10.1016/j.transproceed.2022.03.018.
|
[25] |
BRAUN HJ, GRAB JD, DODGE JL, et al. Retransplantation after living donor liver transplantation: data from the adult to adult living donor liver transplantation study[J], Transplantation, 2021, 105(6): 1297-1302. DOI: 10.1097/ TP.0000000000003361.
|
[26] |
TRIGUERO CABRERA J, ZAMBUDIO CARROLL N, GONZÁLEZ MARTÍNEZ S, et al. Analysis of indications and results in liver retransplantation: is late retransplantation worthwhile?[J]. Transplant Proc, 2018, 50(2): 598-600. DOI: 10.1016/j.transproceed.2017.12.055.
|
[27] |
RHU J, KWON J, LIM M, et al. Graft-recipient-weight ratio and lowered immunosuppression is important for the success of adult liver retransplantation[J]. Sci Rep, 2023, 13(1): 12778. DOI: 10.1038/s41598-023-39007-7.
|
[28] |
BRUBALLA R, SANCHEZ THOMAS D, DE SANTL'BANES E, et al. Liver re-transplantation in adults: indications and outcomes analysis of a 23-year experience in a single center in Argentina[J]. Int J Organ Transplant Med, 2022, 13(2): 30-35.
|
[29] |
AKABANE M, BEKKI Y, IMAOKA Y, et al. Has the risk of liver re-transplantation improved over the two decades?[J]. Clin Transplant, 2023, 37(12): e15127. DOI: 10.1111/ctr.15127.
|
[30] |
IVANICS T, RIZZARI M, MOONKA D, et al. Retransplantation outcomes for hepatitis C in the United States before and after direct-acting antiviral introduction[J]. Am J Transplant, 2021, 21(3): 1100-1112. DOI: 10.1111/ajt.16254.
|
[31] |
KUSEJKO K, NEOFYTOS D, HIRSCH HH, et al. Differences between infectious disease events in first liver transplant versus retransplantation in the Swiss transplant cohort study[J]. Liver Transpl, 2021, 27(9): 1283-1290. DOI: 10.1002/lt.26068.
|
[32] |
CONNOR AA, SAHARIA A, MOBLEY CM, et al. Modern outcomes after liver retransplantation: a single-center experience[J]. Transplantation, 2023, 107(7): 1513-1523. DOI: 10.1097/TP.0000000000004500.
|
[33] |
夏强,沙朦. 活体肝移植的进展与展望[J]. 中华消化外科杂志, 2022, 21(1): 39-42. DOI: 10.3760/cma.j.cn115610-20211205-00622.XIA Q, SHA M. Progress and prospect of living donor liver transplantation[J]. Chin J Dig Surg, 2022, 21(1): 39-42. DOI: 10.3760/cma.j.cn115610-20211205-00622.
|
[34] |
POLAT KY, YAZAR Ş, KARGI A, et al. Comparing the outcomes of deceased-donor and living-donor liver re-transplantation in adult patients[J]. Transplant Proc, 2023, 55(5): 1193-1198. DOI: 10.1016/j.transproceed.2023.01.039.
|
[35] |
IVANICS T, LIMKEMANN A, PATEL MS, et al. Long-term outcomes of retransplantation after live donor liver transplantation: a Western experience[J]. Surgery, 2023, 173(2): 529-536. DOI: 10.1016/j.surg.2022.09.022.
|
[36] |
邢皓, 陶一峰, 徐琳琳, 等. 器官捐献时代再次肝移植单中心回顾性研究[J/OL]. 中华移植杂志(电子版), 2020, 14(6): 343-348. DOI: 10.3877/cma.j.issn.1674-3903.2020.06.002.XING H, TAO YF, XU LL, et al. Single-center retrospective analysis of liver retransplantation in the era of organ donation[J/OL]. Chin J Transplant (Electr Edit), 2020, 14(6): 343-348. DOI: 10.3877/cma.j.issn.1674-3903.2020.06.002.
|
[37] |
LAROCHE S, MAULAT C, KITANO Y, et al. Initial piggyback technique facilitates late liver retransplantation - a retrospective monocentric study[J]. Transpl Int, 2021, 34(5): 835-843. DOI: 10.1111/tri.13857.
|
[38] |
孙晓叶, 沈中阳. 再次肝移植术后免疫抑制剂的应用分析[J/OL]. 实用器官移植电子杂志, 2019, 7(2): 95-98. DOI: 10.3969/j.issn.2095-5332.2019.02.008.SUN XY, SHEN ZY. Application analysis of immunosuppressive agents after liver retransplantation[J/OL]. Pract J Organ Transplant (Electr Vers), 2019, 7(2): 95-98. DOI: 10.3969/j.issn.2095-5332.2019.02.008.
|